Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009

Overview of attention for article published in Bone Marrow Transplantation, October 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 34,701 followers.

<5% in most referral centers these days. It's all about selecting safely :-) https://t.co/wqBP2e1Ef6

RT @DQBMD: NRM with HDM auto for AL amyloidosis significantly reduced. 1994-2001=23.8%. 2002-2009=7.8%. med OS in card AL=49mo. https://t.c…

RT @DQBMD: NRM with HDM auto for AL amyloidosis significantly reduced. 1994-2001=23.8%. 2002-2009=7.8%. med OS in card AL=49mo. https://t.c…

NRM with HDM auto for AL amyloidosis significantly reduced. 1994-2001=23.8%. 2002-2009=7.8%. med OS in card AL=49mo. https://t.co/KjUoDtXWml

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.